Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001493152-23-000616
Filing Date
2023-01-05
Accepted
2023-01-05 16:29:48
Documents
2
Period of Report
2023-01-03

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 1588
2 ex24-1.htm EX-24.1 11192
  Complete submission text file 0001493152-23-000616.txt   14204
Mailing Address 55 BROAD STREET, 2ND FLOOR RED BANK NJ 07701
Business Address 55 BROAD STREET, 2ND FLOOR RED BANK NJ 07701 908-428-9136
Provention Bio, Inc. (Issuer) CIK: 0001695357 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O AKEBIA THERAPEUTICS, INC. 245 FIRST STREET, SUITE 1100 CAMBRIDGE MA 02142
Business Address
Jain Rita (Reporting) CIK: 0001707797 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38552 | Film No.: 23511724